Literature DB >> 7951868

Primary sclerosing cholangitis.

Y Ueno1, N F LaRusso.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7951868     DOI： 10.1007/BF02361256

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  74 in total

1.  Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis.

Authors:  J A Snook; R W Chapman; G K Sachdev; A Heryet; P M Kelly; K A Fleming; D P Jewell
Journal:  J Hepatol       Date:  1989-07       Impact factor: 25.083

2.  Family incidence of primary sclerosing cholangitis associated with immunologic diseases.

Authors:  A D Jorge; C Esley; J Ahumada
Journal:  Endoscopy       Date:  1987-05       Impact factor: 10.093

3.  Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis.

Authors:  J R Cangemi; R H Wiesner; S J Beaver; J Ludwig; R L MacCarty; R R Dozois; A R Zinsmeister; N F LaRusso
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

4.  Familial occurrence of primary sclerosing cholangitis and ulcerative colitis.

Authors:  E M Quigley; N F LaRusso; J Ludwig; R N MacSween; G G Birnie; G Watkinson
Journal:  Gastroenterology       Date:  1983-11       Impact factor: 22.682

5.  Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth.

Authors:  S N Lichtman; E E Okoruwa; J Keku; J H Schwab; R B Sartor
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

Review 6.  The syndrome of disappearing intrahepatic bile ducts.

Authors:  S Sherlock
Journal:  Lancet       Date:  1987-08-29       Impact factor: 79.321

7.  Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients.

Authors:  J H Helzberg; J M Petersen; J L Boyer
Journal:  Gastroenterology       Date:  1987-06       Impact factor: 22.682

8.  Comparative studies of biliary atresia in the human newborn and reovirus-induced cholangitis in weanling mice.

Authors:  B Bangaru; R Morecki; J H Glaser; L M Gartner; M S Horwitz
Journal:  Lab Invest       Date:  1980-11       Impact factor: 5.662

9.  Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.

Authors:  N Kemeny; J Daly; B Reichman; N Geller; J Botet; P Oderman
Journal:  Ann Intern Med       Date:  1987-10       Impact factor: 25.391

10.  Primary sclerosing cholangitis and low-dose oral pulse methotrexate therapy. Clinical and histologic response.

Authors:  M M Kaplan; S Arora; S H Pincus
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391
View more
  5 in total

1.  Colonic cancer in a patient with primary sclerosing cholangitis and long-standing ulcerative colitis.

Authors:  M Seo; M Okada; S Osamura; S Hara; T Umeno; K Maeshiro; Y Yamada; K Yuh
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

2.  ERCP and stent therapy for progressive jaundice in hepatocellular carcinoma: which patients benefit, which patients don't?

Authors:  J A Martin; A Slivka; M Rabinovitz; B I Carr; J Wilson; W B Silverman
Journal:  Dig Dis Sci       Date:  1999-07       Impact factor: 3.199

3.  Sclerosing cholangitis: a rare etiology for acute pancreatitis.

Authors:  C W Imrie; G D Brombacher
Journal:  Int J Pancreatol       Date:  1998-02

4.  Primary sclerosing pancreatitis and cholangitis.

Authors:  H Kazumori; N Ashizawa; N Moriyama; N Arima; K Hirakawa; K Adachi; M Watanabe; Y Kinoshita; K Tamura
Journal:  Int J Pancreatol       Date:  1998-10

5.  Risk factors for developing colorectal cancer in Japanese patients with ulcerative colitis: a retrospective observational study-CAPITAL (Cohort and Practice for IBD total management in Kyoto-Shiga Links) study I.

Authors:  Takuya Yoshino; Hiroshi Nakase; Tomohisa Takagi; Shigeki Bamba; Yusuke Okuyama; Takuji Kawamura; Teruki Oki; Hirozumi Obata; Chiharu Kawanami; Shinji Katsushima; Toshihiro Kusaka; Tomoyuki Tsujikawa; Yuji Naito; Akira Andoh; Takafumi Kogawa
Journal:  BMJ Open Gastroenterol       Date:  2016-11-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.